Patents by Inventor Davinia SALVACHÚA RODRÍGUEZ

Davinia SALVACHÚA RODRÍGUEZ has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ACID TOLERANT CLOSTRIDIA
    Publication number: 20240018556
    Abstract: Clostridium sp. are an obligate anaerobic bacterium that produces butyric acid as its major end-product. Previously, we have developed an integrated process that couples fermentation of biomass sugars, with in situ product recovery and distillation. This process works best at pH's lower than 7.0. The process serves to extract carboxylic acids during fermentation which enables reduced base-loading and reduced end-product toxicity. Disclosed herein are methods and non-naturally Clostridium sp. that are capable of increased production of butyric acid and increased growth at low pH conditions (e.g., pH<5.0).
    Type: Application
    Filed: July 17, 2023
    Publication date: January 18, 2024
    Inventors: Jeffrey George LINGER, Christine Ann SINGER, Lauren Ann Riley DRUMM, Michael T. GUARNIERI, Davinia SALVACHÚA RODRÍGUEZ, Colin Matthew KNEUCKER, Violeta SANCHEZ NOGUE
  • Microorganisms engineered for muconate production
    Patent number: 11781107
    Abstract: Disclosed herein are the genetically modified Pseudomonas with improved tolerance to hydroxycinnamic acids.
    Type: Grant
    Filed: February 24, 2021
    Date of Patent: October 10, 2023
    Assignees: Alliance for Sustainable Energy, LLC, UT-Battelle, LLC
    Inventors: Gregg Tyler Beckham, Christopher W. Johnson, Allison Jean Zimont Werner, Davinia Salvachúa Rodríguez, Daniel A. Jacobson, Erica Teixeira Prates, Elsayed Tharwat Tolba Mohamed, Adam Michael Feist
  • Engineered microorganisms for the production of intermediates and final products
    Patent number: 11518975
    Abstract: The present disclosure relates to a non-naturally occurring microorganism that includes an endogenous genetic deletion that eliminates the expression of at least a pyruvate kinase, where the genetically modified prokaryotic microorganism is capable of producing 3-deoxy-D-arabino-heptulosonate-7-phosphate.
    Type: Grant
    Filed: April 30, 2019
    Date of Patent: December 6, 2022
    Assignees: Alliance for Sustainable Energy, LLC, UT-Battelle, LLC, TRIAD National Security, LLC
    Inventors: Christopher W. Johnson, Peter Corbin St. John, Gregg Tyler Beckham, Joshua Ryan Elmore, Adam Michael Guss, Davinia Salvachua Rodriguez, Gayle Joann Bentley, George Lee Peabody, V, Taraka Dale, Ramesh K. Jha, Niju Narayanan
  • MICROORGANISMS ENGINEERED FOR MUCONATE PRODUCTION
    Publication number: 20210261911
    Abstract: Disclosed herein are the genetically modified Pseudomonas with improved tolerance to hydroxycinnamic acids.
    Type: Application
    Filed: February 24, 2021
    Publication date: August 26, 2021
    Inventors: Gregg Tyler BECKHAM, Christopher W. JOHNSON, Allison Jean ZIMONT WERNER, Davinia SALVACHÚA RODRÍGUEZ, Daniel A. JACOBSON, Erika TEIXEIRA PRATES, Elsayed Tharwat Tolba MOHAMED, Adam Michael FEIST
  • ENGINEERED MICROORGANISMS FOR THE PRODUCTION OF INTERMEDIATES AND FINAL PRODUCTS
    Publication number: 20190367865
    Abstract: The present disclosure relates to a non-naturally occurring microorganism that includes an endogenous genetic deletion that eliminates the expression of at least a pyruvate kinase, where the genetically modified prokaryotic microorganism is capable of producing 3-deoxy-D-arabino-heptulosonate-7-phosphate.
    Type: Application
    Filed: April 30, 2019
    Publication date: December 5, 2019
    Inventors: Christopher W. JOHNSON, Peter Corbin ST. JOHN, Gregg Tyler BECKHAM, Joshua Ryan ELMORE, Adam Michael GUSS, Davinia Salvachua RODRIGUEZ, Gayle Joann BENTLEY, George Lee PEABODY V
  • METABOLIC ENGINEERING FOR ENHANCED SUCCINIC ACID BIOSYNTHESIS
    Publication number: 20170306363
    Abstract: Presented herein are biocatalysts and methods for the production of succinic acid from carbon sources. The biocatalysts include microbial cells that have been engineered to overexpress exogenously added genes that encode enzymes active in the reductive branch of the tricarboxylic acid (TCA) cycle.
    Type: Application
    Filed: April 25, 2017
    Publication date: October 26, 2017
    Inventors: Michael T. GUARNIERI, Yat-Chen CHOU, Gregg Tyler BECKHAM, Davinia SALVACHÚA RODRÍGUEZ